Greater Than One (GTO) has been recognized by PM360 for its success in conceiving and launching a virtual campaign to support OXLUMO® (lumasiran), a first-in-class therapy developed by Alnylam.
Chief Executive Officer and Honeycomb Health (HH) co-founder Elizabeth Apelles discusses why the high-tech nonprofit will forever change the lives of rare disease patients everywhere, and shares the buzz about her co-founder’s road trip to raise $3M dollars.
Explore the GTO POV on how leading with digital health solutions like wearables, social advocacy, and remote monitoring can make a world of difference in diagnosing and treating rare diseases.
